Oncology Today—May 4, 2026
This week’s Oncology update highlights regulatory approvals, NDA submissions…
Respiratory Today—April 30, 2026
This week’s Respiratory update highlights regulatory approvals, advancing…
Immunology Today—April 29, 2026
This week’s Immunology update highlights regulatory actions, clinical progress,…
Respiratory Today—April 24, 2026
This week’s Respiratory Research update highlights regulatory approvals,…
Rare Diseases Today—April 23, 2026
This week’s Rare Diseases update highlights late-stage clinical progress,…
Immunology Today—April 15, 2026
This week’s Immunology update highlights regulatory progress, clinical…
Oncology Today—April 6, 2026
This week’s Oncology update highlights regulatory progress, late-stage clinical…
Lucid Diligence Brief: Syneron Bio completion of $150 million Series B
Lucid Diligence Brief: Syneron Bio completion of $150 million Series B…
Cardiovascular Today—April 2, 2026
This week’s Cardiovascular update highlights regulatory approvals, device…
Cell and Gene Therapy Today—April 2, 2026
This week’s Gene and Cell Therapy update highlights regulatory progress,…
Lucid Diligence Brief: AstraZeneca's tozorakimab meets primary endpoint in COPD
Lucid Diligence Brief: AstraZeneca's tozorakimab meets primary endpoint in……
Oncology Today—March 23, 2026
This week’s Oncology update highlights EU regulatory expansion, late-stage…